 |
|
 |
Production / Manufacturing |
|
|
CRO-EDC Alliances
Implications for CROs, EDC Vendors, and Sponsors
Publication Date August 2005
Publisher Life Science Insights
Product Type Brief
Pages not applicable
ISBN Number not applicable
Product Code LSI017
|
|
|
Summary
This Life Science Insights study examines the move by contract research organizations (CROs) and electronic data capture (EDC) vendors to establish alliance portfolios. It also examines the implications of these alliances for CROs, EDC vendors, and their sponsor customers.
"Drug development companies face significant decisions regarding their EDC deployment. Recent survey data from Life Science Insights suggests that they are interested in increasing their use of EDC over the next 12 months, but first they need to overcome hurdles such as concerns about security, ROI, performance and scalability issues, and interoperability in order to get management buy-in. Next, they must decide if they will buy/lease/outsource EDC deployment via a CRO or buy/lease directly from an EDC vendor," said Scott Lundstrom, vice president of research at Life Science Insights. "CROs with knowledge of several EDC solutions can provide value-added consultative services to drug development companies that may not have a technology preference. Also, when CROs provide examples of successful implementations, it will give sponsors a greater impetus to take advantage of electronic data capture in clinical trials."
Companies Covered
Averion, Cardiocore, Gentiae, I3Statprobe, Inc Research, MMRI, MedTrials, Axio Research Corporation, Octagon Research Solutions, PRA International, Prodmedica International, QDS, SCIREX, United BioSource Corporation, CRO Alliance, CTMS, Research Dynamics, CATO Research, Infoquest, Omnicare, Quintiles, SFBC International, Novotech, Kendle International, Inc., PharmaLink, PPD, Bailer Research, CRDE, Datapharm Australia, US Micron, Duke Clinical Research Institute, Harvard Clinical Research Institute, Parexel, Veristat, ClickFind, DataLabs, DataTrak, eTrials, eResearchTechnologies, LifeTree eClinical, Medidata, NexTrials, Oracle, Phoenix Data Systems, Phase Forward
|
Content
In This Study
Situation Overview
Background on Clinical Data Capture
Figure: Clinical Trials EDC Adoption Now and in 12 Months
Results of CRO Interviews
Preferences
Figure: CRO's Method of Data Capture in Clinical Trials
How CROs Benefit from EDC Relationship
Challenges
Results of EDC Vendor Interviews
Benefits of CRO Alliances
Challenges Associated with CRO Alliances
Examples of CRO-EDC Alliances
Table: Examples of Formal and Informal CRO-EDC Vendor Alliances
Future Outlook
Industry Impact
Implications for Sponsors
Figure: Significance of Technology and Business Hurdles Associated with EDC
Essential Guidance
Learn More
Glossary of Acronyms
Related Research
Synopsis
|
|
|
